The present invention relates to a stable, non-aqueous and ready-to-use injectable composition of a peptide drug or a pharmaceutically acceptable salt or a co-crystal thereof and processes for its preparation. It is not required to reconstitute the injectable composition of the peptide drug with water prior to administration, thereby rendering it an easy-to-use injectable composition.